Cargando…

Can Parvovirus B19 infection be naturally oncolytic: clinical findings raise such a possibility in leukaemic children

Detalles Bibliográficos
Autores principales:	Kishore, Janak, Kishor, Divya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165011/ https://www.ncbi.nlm.nih.gov/pubmed/25109733

Ejemplares similares

Real time PCR reconfirmed three novel clinical associations of parvovirus B19: Non-occlusive bowel gangrene, amegakaryocytic thrombocytopenia & myositis
por: Kishore, Janak
Publicado: (2015)

Clinical impact & pathogenic mechanisms of human parvovirus B19: A multiorgan disease inflictor incognito
por: Kishore, Janak, et al.
Publicado: (2018)

A pilot study on parvovirus B19 infection in paediatric haematological malignancies
por: Kishore, Janak, et al.
Publicado: (2011)

Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors
por: Kishore, Janak, et al.
Publicado: (2010)

Parvovirus B19 infection and B-cell response pattern in unexplained lymphadenopathy
por: Gong, Li, et al.
Publicado: (2023)

Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units
por: Kishore, Janak, et al.
Publicado: (2011)

Oncolytic parvoviruses: from basic virology to clinical applications
por: Marchini, Antonio, et al.
Publicado: (2015)

Seroepidemiology of parvovirus B19 among different age groups & pregnant women in India
por: Viswanathan, Rajlakshmi, et al.
Publicado: (2017)

Morphological study of the ovaries of leukaemic children.
por: Himelstein-Braw, R., et al.
Publicado: (1978)

Raising Money for Hospitals
por: Inch, Frank
Publicado: (1923)

Raising Money for Hospitals
por: Chapman, G. Russell
Publicado: (1923)

Raising Money for Hospitals
por: Fenn, W.
Publicado: (1923)

Prediction of Psychosocial Sequelae in Families of Leukaemic Children
por: Culling, Janice, et al.
Publicado: (1988)

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2014)

Pseudo-Leukæmic Lymphosarcoma
por: Ainley, Norman J.
Publicado: (1949)

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients
por: Angelova, Assia L., et al.
Publicado: (2015)

Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells
por: Ferreira, Tiago, et al.
Publicado: (2022)

Placental abruption possibly due to parvovirus B19 infection
por: Kawabe, Ayaka, et al.
Publicado: (2016)

Single-cell immunofluorescence assay for terminal transferase: Human leukaemic and non-leukaemic cells
por: Okamura, S., et al.
Publicado: (1980)

Substitution rate and natural selection in parvovirus B19
por: Stamenković, Gorana G., et al.
Publicado: (2016)

Oncolytic H-1 Parvovirus Enters Cancer Cells through Clathrin-Mediated Endocytosis
por: Ferreira, Tiago, et al.
Publicado: (2020)

Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
por: Kulkarni, Amit, et al.
Publicado: (2021)

Medical Department, University of Pennsylvania, Raises Its Requirements for Admission
por: Frazier, Charles H.
Publicado: (1907)

Walter Reed Memorial Association: $25,000 to Be Raised. — Subscriptions Solicited
por: DeWitt, C.
Publicado: (1904)

Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2011)

Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis
por: Lacroix, Jeannine, et al.
Publicado: (2014)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
por: Angelova, Assia L., et al.
Publicado: (2017)

A reply to questions raised about FEV(1)Q and bronchodilator responsiveness
por: Miller, Martin R., et al.
Publicado: (2023)

BF.7 Omicron subvariant in India and China: a raising concern – correspondence
por: Sah, Ranjit, et al.
Publicado: (2023)

Proceedings: Surface antigens of leukaemic cells.
por: Greaves, M. F.
Publicado: (1975)

Discovery of α-l-Glucosidase Raises the Possibility of α-l-Glucosides in Nature
por: Shishiuchi, Rikako, et al.
Publicado: (2022)

Activation of a Helper and Not Regulatory Human CD4+ T Cell Response by Oncolytic H-1 Parvovirus
por: Moralès, Olivier, et al.
Publicado: (2012)

Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction
por: Pittman, Nikéa, et al.
Publicado: (2017)

Different distribution of adriamycin in normal and leukaemic rats.
por: Sonneveld, P., et al.
Publicado: (1981)

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
por: Taylor, G. M., et al.
Publicado: (1976)

Transcriptional network control of normal and leukaemic haematopoiesis
por: Sive, Jonathan I., et al.
Publicado: (2014)

The Effect of the Röntgen Ray upon Leukæmic States
Publicado: (1905)

Influence of leukaemic cells on the colony formation of human bone marrow cells in vitro II. Suppressive effects of leukaemic cell extracts.
por: Chiyoda, S., et al.
Publicado: (1976)

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
por: Barnes, Samantha A., et al.
Publicado: (2022)

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers
por: Angelova, Assia L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_asrosdpobq4o2hl1affnibjuuq